Oncotarget
| Language | English |
|---|---|
| Edited by | Mikhail Blagosklonny, Andrei V. Gudkov |
| Publication details | |
| History | 2010-present |
| Publisher | |
| Frequency | Weekly |
| Yes | |
| License | Creative Commons Attribution 3.0 License |
| 5.008 (2015) | |
| Standard abbreviations | |
| ISO 4 | Oncotarget |
| Indexing | |
| ISSN | 1949-2553 |
| OCLC no. | 408119940 |
| Links | |
Oncotarget is a weekly peer-reviewed open access medical journal covering research on all aspects of oncology. The journal was established in 2010 and is published by Impact Journals. The editors-in-chief are Mikhail Blagosklonny and Andrei V. Gudkov (Roswell Park Cancer Institute).
Abstracting and indexing
The journal is abstracted and indexed in Index Medicus/MEDLINE/PubMed,[1] BIOSIS Previews,[2] the Science Citation Index Expanded,[2] and Scopus.[3]
Reception
The reviewing process employed by the journal has been criticized by Jeffrey Beall,[4] who also included the journal on his list of "potential, possible, or probable predatory scholarly open-access journals"[5] in July 2015.[4]
According to the Journal Citation Reports, the journal has a 2015 impact factor of 5.008 (3.757 without journal self cites).[6]
References
- ^ "Oncotarget". NLM Catalog. National Center for Biotechnology Information. Retrieved 2016-04-19.
- ^ a b "Master Journal List". Intellectual Property & Science. Thomson Reuters. Retrieved 2016-04-19.
- ^ "Content overview". Scopus. Elsevier. Retrieved 2016-04-19.
- ^ a b Beall, Jeffrey (19 April 2016). "Oncotarget's Peer Review is Highly Questionable". Scholarly Open Access. WordPress.com. Retrieved 19 April 2016.
- ^ Beall, Jeffrey (16 April 2016). "LIST OF STANDALONE JOURNALS: Potential, possible, or probable predatory scholarly open-access journals". Scholarly Open Access. WordPress.com. Retrieved 19 April 2016.
- ^ "Oncotarget". 2015 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2016.